Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSOGEN: Adalimumab for self-esteem and sexual functioning in anogenital psoriasis
NL-OMON33188Phase 4Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of adalimumab in psoriasis and genital psoriasis, sponsored by Amsterdam University Medical Center. Primary endpoint: Change in questionnaire scores. Started Sep 2010; status: recruiting.
02
Drugs
03
Conditions
psoriasisgenital psoriasis
Beyond the preview
Go deeper on NL-OMON33188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33188.